Lyndra Therapeutics

Lyndra Therapeutics, a pioneering biotechnology company formerly located in Watertown, Massachusetts, was dedicated to transforming the landscape of medication adherence. With a focus on innovation, Lyndra Therapeutics aimed to improve patient outcomes through the development of novel drug delivery systems.

Lyndra Therapeutics operated out of its primary address at 65 Grove St, Suite 301, Watertown, Massachusetts 02472, US, and another location at 60 Westview St, Lexington, Massachusetts 02421, US. The company strived to address the challenges associated with patient compliance, creating solutions that could potentially revolutionize chronic disease management.

While Lyndra Therapeutics has ceased operations as of March 26, 2025, its contributions to the biotechnology field remain significant. The company's vision and commitment to innovation have left a lasting impact. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight Lyndra Therapeutics' achievements.